secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pediatrix Medical Group, Inc. (MD)
CIK:        0000893949
Form:       8-K
Filed at:   2025-07-01T23:59:59+00:00
Accession:  0000950170-25-092261
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pediatrix appoints Dr. Kurt Newman as independent director effective July 1, 2025
--------------------------------------------------------------------------------

- Dr. Newman, former President & CEO of Children's National Hospital for 12 years, appointed to board.
- He is a pediatric surgeon and professor emeritus, bringing clinical insight and healthcare leadership.
- Receives standard non-employee director compensation; enters indemnification agreement with company.
- No arrangements with other persons regarding his appointment; no committee assignments yet determined.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/893949/000095017025092261/0000950170-25-092261-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/893949/000095017025092261/md-20250701.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-092261

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer